Related Experiment Video
Updated: Jun 11, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder
Akiko Okuda1, Tatsuyo Suzuki, Taro Kishi
1Department of Psychiatry, Okehazama Hospital Fujita Mental Care Center, Aichi, Japan. akkon-o@fujita-hu.ac.jp
Aims:
The aim of this study was to analyze the relation between treatment response and the duration of untreated illness (DUI) in 133 outpatients with the first major depressive disorder (MDD) episode.
Methods:
A logistic regression was performed with DUI, sex, age at onset, and score for 17 items on the Hamilton Depression Rating Scale at the time of start of fluvoxamine treatment as the explanatory variables, and the response and the remission as the outcome variables.
Results:
Regression analysis showed significant association between the response and DUI (P < 0.0001), and between the remission and DUI (P < 0.0001), respectively. The remission rate gradually decreased with longer DUI.
Conclusion:
Early treatment of first depressive episodes is important because a shorter DUI implied better remission outcomes.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
